At a recent town hall, an Oklahoma constituent asked Rep. Josh Brecheen (R–OK2) two simple, kitchen-table questions: Did Donald Trump really lower prescription drug prices, as he often claims? And what bills has Congress passed to ease grocery costs for struggling families?
Instead of providing clarity, Rep. Brecheen sidestepped.
“Ma’am, you’re talking about things relative to state level,” Brecheen said, before launching into a lecture on the 18 enumerated powers of Congress and the 10th Amendment. “What I’m saying to you is, Oklahoma, if you want to have that conversation about grocery taxes, they’ve been having that conversation.”
His response may have pleased constitutional purists, but it left many constituents unsatisfied—especially given that President Trump, the leader of Brecheen’s own party, campaigned in 2016 and 2024 on a promise to bring down the cost of drugs.
Trump’s 2016 and 2024 Promises on Drug Prices
When Donald Trump ran for president in 2024, he vowed to take on “price-gouging” pharmaceutical companies and lower drug costs for ordinary Americans. Among his boldest pledges: allowing Medicare to negotiate drug prices directly with manufacturers, a step he claimed could save up to $300 billion annually.
Trump also promised to import cheaper drugs from abroad and tie U.S. prices to lower costs in other countries. “We’re going to get the best deals,” Trump said on the campaign trail.
But once in office, those promises largely fell short. His administration released a blueprint, American Patients First, and issued several executive orders. Yet most of the proposals were either blocked in court, watered down, or never implemented. By the end of his presidency, drug costs remained a top concern for American families.
Brecheen’s Deflection on Drug Prices and Grocery Costs
Given that context, the Oklahoma constituent’s question was not only fair but timely: How does Trump’s record on drug prices square with his boasts of success?
Rather than acknowledge the gap between promise and outcome—or cite any specific Republican initiatives—Rep. Brecheen shifted blame to state governments and offered no examples of federal legislation addressing either drug or grocery costs.
The exchange ended abruptly, with Brecheen moving to another questioner.
“Who’s next?” the Rep. Brecheen asked abruptly.
The Disconnect Between Rhetoric and Reality
For voters in Oklahoma’s 2nd Congressional District, the moment exposed a deeper problem: the widening gulf between campaign rhetoric and lived reality.
Trump promised cheaper medicine. Republicans regularly rail against inflation and the high cost of groceries. Yet when pressed, their representatives too often deflect to ideology rather than explain concrete solutions.
In communities where families are choosing between prescriptions and food, theoretical discussions about enumerated powers ring hollow. Constituents aren’t asking for a constitutional seminar—they’re asking for help.
A Missed Opportunity
Rep. Brecheen could have acknowledged Trump’s promises, explained the hurdles his party faced in implementing them, and pointed to ongoing GOP efforts like promoting generic drugs or expanding competition. Instead, he avoided the substance of the questions altogether.
For constituents, the takeaway is clear: promises made on the 2016 and 2024 campaign trails remain largely unfulfilled, and their representative isn’t eager to talk about it.
4) Purpose-driven message
Asia Communities Network-ikhmerr